Skip to content

Stent assisted Liang’s Internal drainage Trabecular Surgery in Primary Glaucoma (SLITS)

Stent assisted Liang’s Internal drainage Trabecular Surgery in Primary Glaucoma (SLITS)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300074779
Enrollment
Unknown
Registered
2023-08-16
Start date
2023-08-11
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

SLITS group:Stent assisted Liang’s Internal drainage Trabecular Surgery

Sponsors

The Eye Hospital of Wenzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1)According to the "Chinese Glaucoma Guidelines", glaucoma patients have indications for surgery, such as patients with medications intolerated, poor results of traditional filtration surgery or a tendency towards scarring; 2)aged 18 to 75 years old 3)Patients with open-angle glaucoma with two or more glaucoma medications with IOP > 21 mmHg; 4)Voluntarily participate in this clinical trial and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1)Patients in acute attack phase of acute angle-closure glaucoma; 2) malignant glaucoma, secondary glaucoma due to active uveitis or neovascular glaucoma. 3)Preoperative IOP =40mmHg; 4)axis length 28mm; 5)BCVA of contralateral eye<0.3; 6)Patients who require a combination of other surgeries that may affect the reliability of IOP; 7)Patients with a history of corneal refractive surgery. 8)Patients with a history of allergy to anesthetic drugs or nitinol; 9)Patients with corneal dystrophy, active corneal inflammation, or ocular tumors; 10)Patients with diseases such as thyroid associated ophthalmopathy, eye diseases with elevated episcleral venous pressure, etc. that affect the surgical evaluation; 11)Pregnant and lactating women; 12)Inability to cooperate with the surgery; 13)Have participated in other clinical trials within 30 days prior to this enrollment and may affect the evaluation of this clinical trial; 14)Other situations in which the investigator deemed inappropriate to participate in this trial;

Design outcomes

Primary

MeasureTime frame
surgical success rate;IOP;glaucoma medications;

Secondary

MeasureTime frame
stent injected rate;transient IOP elevation;stent dislodgement rate.;

Countries

China

Contacts

Public ContactYuanbo Liang

The Eye hospital of Wenzhou Medical University

yuanboliang@126.com+86 182 5774 8686

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026